NxStage
{{Infobox company
| name = NxStage Medical, Inc.
| logo = File:NxStage website logo.png
| type = Subsidiary
| industry = Medical devices
| founded = {{Start date and age|1998|12}}
| founder = C. David Finch, Jr., MD and Jeffrey H. Burbank
| products = System One
| hq_location_city = Lawrence, Massachusetts
| hq_location_country = U.S.
| revenue = {{increase}} $393 million (2017)
| net_income = {{increase}} -$14 million (2017)
| assets = {{increase}} $325 million (2017)
| equity = {{increase}} $213 million (2017)
| num_employees = 3,800 (2017)
| parent = Fresenius Medical Care
| website = {{URL|https://www.nxstage.com/}}
| footnotes = {{cite web | url=https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm20171231-10k.htm | title=NxStage Medical, Inc. 2017 Form 10-K Annual Report | publisher=U.S. Securities and Exchange Commission}}
}}
NxStage Medical, Inc. ({{IPAc-en|ˈ|n|ɛ|k|ˌ|s|t|eɪ|dʒ}} {{Respell|NEK|stayj}}{{cite web|url=https://www.youtube.com/watch?v=ODLYNrbJf5IVersiHD | title=VersiHD with GuideMe Software Overview Animated Video |website=YouTube|date=October 27, 2023|accessdate=1 June 2024}}) is an American company that develops, manufactures, and markets systems for the treatment of chronic kidney disease, acute kidney injury, and hypervolemia. It is a subsidiary of Fresenius Medical Care. System One, a portable hemodialysis system, is the company's primary product.
History
The company was founded by C. David Finch, Jr., MD{{Cite web|url=https://eliteamericanphysicians.com/2014/01/10/cdavid-finchjrmd/|archive-url=https://web.archive.org/web/20191024200116/https://eliteamericanphysicians.com/2014/01/10/cdavid-finchjrmd/|url-status=usurped|archive-date=October 24, 2019|title=C. David Finch Jr. MD|last=Who|first=Marquis Who's|date=2014-01-10|website=Elite American Physicians|language=en|access-date=2019-10-24}} and Jeffrey H. Burbank in December 1998.{{cite web | url=https://www.bloomberg.com/research/stocks/private/person.asp?personId=588131&privcapId=242153333 | title=Company Overview of NxStage Kidney Care, Inc | date=15 July 2023 | publisher=Bloomberg L.P.}}
In 2003, the company launched System One in the critical care market. It received Food and Drug Administration clearance for home hemodialysis in June 2005.{{cite press release | url=https://www.businesswire.com/news/home/20050629005365/en/NxStage-Medical-Receives-FDA-Clearance-Home-Hemodialysis | title=NxStage Medical Receives FDA Clearance for Home Hemodialysis System | publisher=Business Wire | date=June 29, 2005}}
In October 2005, the company became a public company via an initial public offering.{{cite news | url=https://www.bizjournals.com/boston/blog/mass-high-tech/2005/10/nxstage-medical-rolls-out-lower-priced-ipo.html | title=NxStage Medical rolls out lower-priced IPO | work=American City Business Journals | date=October 24, 2005}}
On November 2, 2005, the company received the Nixon Peabody/Smith&Nephew Medical Device Innovation Award in the Start-Up category from the Massachusetts Medical Device Industry Council (MassMEDIC).{{cite press release | url=https://www.businesswire.com/news/home/20051102005156/en/MassMEDIC-Honors-NxStage-Medical-Innovation-Award-Portable | title=MassMEDIC Honors NxStage Medical with Innovation Award for Portable Home Hemodialysis System | publisher=Business Wire | date=November 2, 2005}}
In December 2014, the company received Food and Drug Administration clearance for System One to be used overnight while patients are sleeping.{{cite news | url=https://www.bizjournals.com/boston/blog/bioflash/2014/12/nxstage-nabs-first-ever-fda-approval-for-overnight.html | title=NxStage nabs first-ever FDA approval for overnight home hemodialysis | first=Don | last=Seiffert | work=American City Business Journals | date=December 29, 2014}}
In August 2017, the company received Food and Drug Administration clearance for System One for solo home hemodialysis, without a care partner, during waking hours.{{cite press release | url=https://www.prnewswire.com/news-releases/nxstage-medical-announces-fda-clearance-for-solo-home-hemodialysis-using-nxstage-system-one-300509804.html | title=NxStage Medical Announces FDA Clearance for Solo Home Hemodialysis Using NxStage® System One™ | publisher=PR Newswire | date=August 28, 2017}}
In February 2019, the company was acquired by Fresenius Medical Care.{{cite news | url=https://www.modernhealthcare.com/article/20190226/NEWS/190229935/fresenius-medical-care-closes-2-billion-nxstage-acquisition | title=Fresenius Medical Care closes $2 billion NxStage acquisition | first=TARA | last=BANNOW | work=Modern Healthcare | date=February 26, 2019}}{{cite press release | url=https://www.prnewswire.com/news-releases/fresenius-medical-care-completes-acquisition-of-nxstage-medical-300801800.html | title=Fresenius Medical Care completes acquisition of NxStage Medical | publisher=PR Newswire | date=February 26, 2019}}
References
{{Reflist|1}}
External links
- {{Official website|https://www.nxstage.com/}}
Category:American companies established in 1998
Category:Health care companies established in 1998
Category:Health care companies based in Massachusetts
Category:1998 establishments in Massachusetts
Category:2005 initial public offerings
Category:2019 mergers and acquisitions
Category:Companies based in Lawrence, Massachusetts
Category:Companies formerly listed on the Nasdaq
Category:Medical device manufacturers